Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) FCF Margin (2021 - 2022)

Actinium Pharmaceuticals (ATNM) has disclosed FCF Margin for 2 consecutive years, with 12862.22% as the latest value for Q3 2022.

  • On a quarterly basis, FCF Margin fell 1043475.0% to 12862.22% in Q3 2022 year-over-year; TTM through Jun 2023 was 94277.78%, a 9517641.0% decrease, with the full-year FY2023 number at 58627.16%, down 5943085.0% from a year prior.
  • FCF Margin was 12862.22% for Q3 2022 at Actinium Pharmaceuticals, down from 61440.0% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 61440.0% in Q2 2022 to a low of 21965.22% in Q4 2021.